Related Experiment Video
Updated: Dec 11, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Plasma ceramides are associated with coronary atherosclerotic burden in patients with ST-segment elevation myocardial
Weili Pan1, Longyan Li2, Meng Sun1
1Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Province Heilongjiang, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, Province Heilongjiang, China.
Insights
Elevated plasma ceramides (Cer) are linked to higher atherosclerotic burden in ST-segment elevation myocardial infarction (STEMI) patients. These findings suggest ceramides play a proatherogenic role in cardiovascular disease.
Area of Science:
- Cardiovascular Research
- Lipidomics
- Biochemistry
Background:
- Plasma ceramides (Cer) are bioactive lipids implicated in the pathogenesis of atherosclerotic coronary artery disease (CAD).
- Ceramides are associated with major adverse cardiovascular events (MACEs).
Purpose of the Study:
- To investigate the association between plasma ceramide levels and the extent of atherosclerotic burden.
- To evaluate atherosclerotic burden using the Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score.
Main Methods:
- Retrospective analysis of 248 ST-segment elevation myocardial infarction (STEMI) patients.
- Plasma ceramide concentrations were measured using Rapid Resolution Liquid Chromatography coupled with Quadrupole Time-of-Flight Mass Spectrometry (RRLC-Q-TOF/MS).
- SYNTAX scores were automatically calculated.
Main Results:
- STEMI patients exhibited higher plasma ceramide levels compared to normal donors (p < .001).
- Positive correlations were observed between SYNTAX score and specific ceramides: Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/24:1), and Cer(d18:1/24:0).
- Higher levels of Cer(d18:1/16:0), Cer(d18:1/18:0), and Cer(d18:1/24:1) were independently associated with higher SYNTAX scores after adjusting for traditional risk factors.
Conclusions:
- Elevated plasma levels of Cer(d18:1/16:0), Cer(d18:1/18:0), and Cer(d18:1/24:1) are independent predictors of high atherosclerotic burden in STEMI patients.
- These findings support a proatherogenic role for ceramides in cardiovascular disease.
Background:
Plasma ceramides (Cer), a subset of bioactive lipids, have mechanistic links to atherosclerotic coronary artery disease (CAD) pathogenesis and are related to major adverse cardiovascular events (MACEs).
Objectives:
This study aimed to explore the associations between plasma Cer and atherosclerotic burden evaluated by Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score.
Methods And Results:
A retrospective series of 248 ST-segment elevation myocardial infarction (STEMI) patients undergoing interventional procedures and plasma ceramides measurement were enrolled. Rapid resolution liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (RRLC-Q-TOF/MS) was used to evaluate plasma Cer concentrations. SYNTAX score was automatically calculated on the SYNTAX website (http://www.syntaxscore.com/). Patients with STEMI had higher plasma MACEs-related ceramide levels than normal donors (p < .001). Pearson correlation analysis showed positive correlations between SYNTAX score and Cer(d18:1/16:0) (r = 0.176, p = .006), Cer(d18:1/18:0) (r = 0.290, p < .001), Cer(d18:1/24:1) (r = 0.209, p = .001) and Cer(d18:1/24:0) (r = 0.134, p = .036). Adjustments for all traditional risks, higher Cer(d18:1/16:0) level (per SD increase, β (95%CI) =10.681 (1.912-19.923), p = .032), Cer(d18:1/18:0) level (per SD increase, β (95%CI) =38.830 (15.444-62.126), p = .001), Cer(d18:1/24:1) level (per SD increase, β (95%CI) =6.122 (1.640-10.605), p = .008) (except for and Cer(d18:1/24:0) level (per SD increase, β (95%CI) =0.999 (-0.508-2.506), p = .193)) were independently associated with higher levels of SYNTAX score.
Conclusions:
Elevated plasma levels of Cer (d18:1/16:0), Cer(d18:1/18:0) and Cer(d18:1/24:1)) are independent predictors for a high atherosclerotic burden in patients with STEMI. Our findings provide evidence supporting proatherogenic roles of Cer.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT